Pathologic Diagnosis in Amyloidosis JungSun Kim MD Ph

  • Slides: 22
Download presentation
 Pathologic Diagnosis in Amyloidosis Jung-Sun Kim, MD Ph. D Department of Pathology Samsung

Pathologic Diagnosis in Amyloidosis Jung-Sun Kim, MD Ph. D Department of Pathology Samsung Medical Center Sungkyunkwan University School of Medicine

Amyloidosis • A heterogeneous group of diseases of diverse origin • Caused by extracellular

Amyloidosis • A heterogeneous group of diseases of diverse origin • Caused by extracellular deposition of misfolded, insoluble aggregated proteins with a characteristic -pleated sheet configuration

Structure of Amyloid • Crystallography: Cross- -pleated sheet conformation • EM: Continuous nonbranching fibrils

Structure of Amyloid • Crystallography: Cross- -pleated sheet conformation • EM: Continuous nonbranching fibrils with a diameter of 7. 5 to 10 nm

Amyloid Fibril Formation Dember, Kidney Int 2005; 68: 1377– 90

Amyloid Fibril Formation Dember, Kidney Int 2005; 68: 1377– 90

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14:

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14: 179 -83

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14:

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14: 179 -83

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14:

Amyloid Proteins and their Precursors in Human Westermark et al. , Amyloid 2007; 14: 179 -83

Classification of Amyloidosis Clinicopathologic Category Associated Diseases Major Fibril Protein Chemically Related Precursor Protein

Classification of Amyloidosis Clinicopathologic Category Associated Diseases Major Fibril Protein Chemically Related Precursor Protein AL Immunoglobulin light chains, chiefly λ type AA SAA SYSTEMIC (GENERALIZED) AMYLOIDOSIS Multiple myeloma and other Immunocyte dyscrasias with amyloidosis monoclonal plasma cell (primary amyloidosis) Proliferations Reactive systemic amyloidosis Chronic inflammatory (secondary amyloidosis) Conditions Hemodialysis-associated amyloidosis Chronic renal failure Aβ 2 m β 2 -microglobulin HEREDITARY AMYLOIDOSIS Familial Mediterranean fever AA SAA Familial amyloidotic neuropathies (several types)   ATTR Transthyretin SENILE SYSTEMIC AMYLOIDOSIS   ATTR Transthyretin LOCALIZED AMYLOIDOSIS Senile cerebral Alzheimer disease A APP Endocrine Medullary carcinoma of thyroid Islets of Langerhans Isolated atrial amyloidosis Type 2 diabetes   A Calcitonin AIAPP Islet amyloid peptide AANF Atrial natriuretic factor

Detection of Amyloid • Congo red stain: the gold standard – Salmon-pink color in

Detection of Amyloid • Congo red stain: the gold standard – Salmon-pink color in bright field – Apple-green birefringent deposits under polarized light – Good fixation, strong light source in a darkened room, thicker sections, multiple sections

Detection of Amyloid • Electron microscopic demonstration of the fibrillar nature of deposits

Detection of Amyloid • Electron microscopic demonstration of the fibrillar nature of deposits

Detection of Amyloid • Thioflavin S & T • Methyl violet • Sulphonated Alcian

Detection of Amyloid • Thioflavin S & T • Methyl violet • Sulphonated Alcian blue – less sensitive – less specific

Amyloid Typing • Need to have stringent criteria • Indistinguishable on LM or EM

Amyloid Typing • Need to have stringent criteria • Indistinguishable on LM or EM • Most direct (but not applicable in reality) – Mass spectrometry – Amino acid sequencing • In clinical setting – immunostaining

Amyloid Typing • Immunohistochemistry: – Currently the standard – Kappa, Lambda, Amyloid A, Transthyretin

Amyloid Typing • Immunohistochemistry: – Currently the standard – Kappa, Lambda, Amyloid A, Transthyretin for primary screening Kappa Lambda Amyloid A

Amyloid Typing • Immunohistochemistry: – Limitation • Nonreactive with a truncated light chain •

Amyloid Typing • Immunohistochemistry: – Limitation • Nonreactive with a truncated light chain • Limited antibody panel missing a number of hereditary amyloidoses • Background staining : “locking-in” of serum proteins during fixation

Amyloid Typing • Immunofluorescence – Cleaner background – Higher Sensitivity – Limitation: requirement of

Amyloid Typing • Immunofluorescence – Cleaner background – Higher Sensitivity – Limitation: requirement of frozen tissue Collins et al. , Cardiovasc Pathol 2009; 18: 205 -16

Amyloid Typing • Combined Congo red and IHC • Immuno-electron microscopy • Western blotting

Amyloid Typing • Combined Congo red and IHC • Immuno-electron microscopy • Western blotting

The Choice of Tissue Specimen: Fat as a Source of Tissue for Amyloid Detection

The Choice of Tissue Specimen: Fat as a Source of Tissue for Amyloid Detection • Biopsy of a clinically affected organ • Subcutaneous fat pad biopsy: less invasive screening test • To judge systemic versus local amyloidosis

Biopsy-Proven Amyloidosis in SMC (2000. 1 – present; by Congo red or EM) •

Biopsy-Proven Amyloidosis in SMC (2000. 1 – present; by Congo red or EM) • • • Kidney: 37 Heart: 35 Gastrointestinal tract: 34 Skin and soft tissue: 13 Respiratory tract: 12 Bone (marrow): 11 Liver, pancreatobiliary tract: 7 Thyroid: 5 (medullary carcinoma) Thymus, Urinary bladder, Seminal Vesicles, Peripheral Nerve, Eye, Lacrimal gland

Amyloid Typing in Kidney Biopsy by Immunohistochemistry • 23 Kidney biopsies in which IHC/IF

Amyloid Typing in Kidney Biopsy by Immunohistochemistry • 23 Kidney biopsies in which IHC/IF stainings were done – 6 AA type (Amyloid A (+); kappa/lambda (+/-) – 17 AL type (Amyloid A (-): kappa/lambda (+)) • 1 kappa • 6 lambda • 10 not determined EM: non-branching fibrils

Amyloid Typing in Heart Biopsy by Immunohistochemistry Patient Age Sex kappa lambda amyloid A

Amyloid Typing in Heart Biopsy by Immunohistochemistry Patient Age Sex kappa lambda amyloid A Type 1 51 M P N N AL kappa 2 72 M P N N AL kappa 3 50 F P WP N AL kappa 4 58 F N P N AL lambda 5 74 M WP P N AL lambda 6 64 M WP P ND AL lambda 7 60 M WP P N AL lambda 8 57 M WP P N AL lambda 9 71 M WP WP N AL 10 58 M WP WP N AL N, negative; ND, not done; P, positive; WP, weak positive

Summary • Detection of Amyloid – Congo Red staining – EM • Diagnosis of

Summary • Detection of Amyloid – Congo Red staining – EM • Diagnosis of the Amyloid type – Immunohistochemistry – Immunofluorescent staining

HE Congo Red Kappa Lambda Amyloid A

HE Congo Red Kappa Lambda Amyloid A